Loading viewer...
earnings
Format: PDF earnings
Henlius reports first-half 2022 financial and operational results, covering commercial operations, innovative biologics R&D progress, biosimilar development milestones, and manufacturing capacity expansion. The presentation details clinical and pre-clinical phase advancements in biopharmaceutical development.
annual_report
44 Pages
earnings
28 Pages
Unknown
Alijarah Holding Q3 2022 Earnings Conference Call
earningsearnings
8 Pages
Alijarah Holding Company
Stanbic Holdings 1H23 Financial Results Presentation
earningsearnings
28 Pages
Stanbic Holdings PLC